Skip to content

Perioperative Transfusion Related Outcome

Effect of Perioperative Transfusion on Early and Late Outcome After Major Elective Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03930355
Enrollment
6121
Registered
2019-04-29
Start date
2019-05-01
Completion date
2020-12-30
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion

Keywords

Surgery, Perioperative, Transfusion, Mortality

Brief summary

A secondary analysis of the Turkish National Perioperative Transfusion Study (TULIP TS) database will be performed.

Detailed description

The Turkish National Perioperative Transfusion Study (TULIP TS) was conducted by The Turkish Society of Anesthesiologists' Multicentre Clinical Trials Network. TULIP TS included 6481 patients undergoing major elective surgery, from 61 study sites across the country. Transfusion practices of clinicians working at diverse surgical fields; differences between current transfusion practices and patient blood management strategies; the areas for improvement and the obstacles that could prevent change were evaluated and identified. Data relevant to perioperative transfusion rates of red blood cells, fresh frozen plasma and platelets, the indications for transfusion and postoperative adverse outcomes including 1 month all cause mortality was obtained. The TULIP TS group aims to collect further data concerning 1 year all cause mortality of the same patient population and to evaluate adverse outcomes in transfused and non transfused patients.

Interventions

OTHERBlood transfusion

Patients who received blood transfusion in the perioperative period

OTHERControl

Patients who did not receive blood transfusion in the perioperative period

Sponsors

Diskapi Teaching and Research Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 100 Years
Healthy volunteers
No

Inclusion criteria

• Patients undergoing major elective surgery

Exclusion criteria

• Trauma patients, emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
1 year all cause mortalitypostoperative 366th dayNumber of participants died: all cause mortality
Acute kidney injurypostoperative 30th dayNumber of participants with acute kidney injury
Acute respiratory failurepostoperative 30th dayNumber of participants with acute respiratory failure
Thromboembolic eventpostoperative 30th dayNumber of participants with a thromboembolic event
Ischemic eventpostoperative 30th dayNumber of participants with an ischemic event
Infectionpostoperative 30th dayNumber of participants with infection
Myocardial infarctionpostoperative 30th dayNumber of participants with myocardial infarction
Adverse cardiac eventpostoperative 30th dayNumber of participants with an adverse cardiac event

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026